XML 94 R73.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Reporting - Summary of Significant Segment Expenses (Details) - USD ($)
$ in Thousands
 12 Months Ended
Oct. 31, 2025
Oct. 31, 2024
Research and development expenses:    
Total research and development expenses $ 94,480 $ 38,315
General and administrative expenses:    
Other general and administrative expenses 11,471 11,951
Total general and administrative expenses 28,685 23,982
Other segment items (5,863) (7,155)
Net loss 117,302 55,142
Chemistry, Manufacturing and Controls    
Research and development expenses:    
Total research and development expenses 49,578 11,994
Clinical Operations    
Research and development expenses:    
Total research and development expenses 17,915 11,036
Other Research and Development Expenses    
Research and development expenses:    
Total research and development expenses 7,052 4,598
Personnel-Related Expenses Excluding Stock-Based Compensation    
Research and development expenses:    
Total research and development expenses 16,653 8,893
General and administrative expenses:    
Total general and administrative expenses 10,850 8,501
Stock Based Compensation    
Research and development expenses:    
Total research and development expenses 3,282 1,794
General and administrative expenses:    
Total general and administrative expenses $ 6,364 $ 3,530